Developer docs
API playgroundTry for free, no card

Search company profiles

SignalPath

Full company profile

uuid0002g6s

Namestring
SignalPath
Websiteurl
signalpath.com
Company typeenum
Private
Founded yearint
2014
Descriptiontext

SignalPath is a U.S.-based clinical research software company founded in 2014 and headquartered in Raleigh, North Carolina. The company designs and develops Clinical Trial Management System (CTMS) software intended to improve the operational ease, efficiency, and quality of clinical research at the site and sponsor level. Its core product is a site-focused CTMS that addresses the workflow complexity, data tracking, and quality control demands faced by clinical research organizations conducting trials.

The company's technology stack is built around a proprietary CTMS platform that has been integrated into Verily's broader Viewpoint solution suite — a multi-product offering covering clinical research acceleration, alongside Verily's other products (Pre, Lightpath, Sightline, and Verily Me). The platform positions itself as an enterprise solution for clinical research sites, with a sales-led go-to-market model evidenced by a "Request a demo" engagement flow on the product page. The underlying technology is described within the Viewpoint suite as part of an AI-native precision health platform, indicating architectural alignment with modern, data-driven clinical research workflows.

SignalPath's business model is enterprise B2B SaaS, monetizing through site-level CTMS licenses sold to clinical research organizations and sponsors. The company scaled to 51–100 employees and raised approximately $34.5M across five funding rounds between 2014 and 2019, culminating in a $18M Series 2 in October 2019. The company was subsequently acquired by Verily (an Alphabet subsidiary), where the SignalPath CTMS now operates as Viewpoint Site CTMS within Verily's portfolio. No standalone revenue, customer counts, or pricing details are publicly disclosed.

Short descriptiontext

SignalPath is a Raleigh-based clinical research software company building a Clinical Trial Management System (CTMS) for clinical research sites and sponsors, now operating as Verily's Viewpoint Site CTMS within Alphabet's precision health platform.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersRaleigh, United States
HQ citystring
Raleigh
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
clinical trial software, clinical research management, clinical trial management system, research site operations, sponsor clinical software
Industry3 codes
PRIMARYHLACAOAD
Clinical Trial Management Systems (CTMS)
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)
SECONDARYHLACAOAL
Decentralized/Hybrid Trial Enablement (DCT) Platforms
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)
SECONDARYHLAGAJAM
Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
NAICS code2 codes
  • Custom Computer Programming Services541511
  • Computer Systems Design Services541512
SIC code2 codes
  • Services-Prepackaged Software7372
  • Services-Commercial Physical & Biological Research8731
Product category
Clinical Trial Management Software
Social media profiles2 records
Marketing channels1 record

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Technology or R&D, Marketing or Sales, Operations
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

SignalPath designs and provides the next generation of software for the clinical research site and sponsor. Its flagship offering is a Clinical Trial Management System (CTMS) engineered to improve the ease, efficiency, and quality of clinical research operations for research sites and sponsor organizations.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Verily offers a multi-product solution suite called Viewpoint designed to accelerate clinical research. Viewpoint Site CTMS is the core clinical trial management system offering within this suite, focused on improving operational aspects of site-level clinical trials. The Viewpoint suite is part of Verily's broader precision health platform alongside products like Pre (AI-native platform), Lightpath (personalized care), Sightline (population disease monitoring), and Verily Me (personal health companion).

Product and service1 record
1Viewpoint Site CTMS
CategoryClinical Trial Management System (CTMS)
Description

A Clinical Trial Management System (CTMS) designed to improve the ease, efficiency, and quality of clinical research operations for clinical research sites and sponsor organizations.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Veeva Systems is the dominant vendor of CTMS, eTMF, EDC and broader clinical operations software to pharma sponsors and CROs. It is the most direct competitor to SignalPath in the CTMS space and is the benchmark incumbent for clinical research SaaS.

TypeDirect peer
Description

Castor provides a clinical trial platform spanning EDC, ePRO and CTMS-style functionality for sites and sponsors. It is an emerging direct peer targeting the same decentralized trial buyer with a modern cloud-native product.

TypeBroad incumbent
Description

Medidata offers the Rave CTMS module alongside EDC, eCOA and the Patient Cloud decentralized trial suite. As a broad incumbent owned by Dassault Systèmes, it competes with SignalPath across both sponsor and site clinical operations software.

TypeDirect peer
Description

Bio-Optronics builds the Clinical Conductor CTMS used by research sites and site management organizations. It is a direct competitor focused on the same research site buyer that SignalPath targets.

TypeDirect peer
Description

Advarra offers a CTMS (OnCore) alongside IRB and biosafety services targeting academic medical centers and research sites. It directly competes with SignalPath at the site level and is one of the most established site-focused CTMS products in the market.

TypeBroad incumbent
Description

IQVIA bundles CTMS, EDC, and the broader IQVIA Platform alongside its CRO services. As a broad incumbent CRO-plus-software player, it competes with SignalPath both directly (CTMS) and via integrated services-plus-tech bundles that can foreclose independent site software.

TypeBroad incumbent
Description

Clario delivers eCOA, ECG, imaging and clinical trial software spanning site and sponsor buyers. It is a broad incumbent with overlapping DCT and clinical operations capabilities that compete with the Viewpoint Site CTMS positioning.

TypeEmerging player
Description

Prism provides CTMS alternatives such as the eResearch suite for academic and community research sites. It is an emerging peer competing for the same site-level buyer with comparable functionality.

TypeDirect peer
Description

RealTime delivers CTMS and eRegulatory solutions for research sites and SMOs. It competes head-on with SignalPath in the investigator-site CTMS category with comparable pricing and SaaS delivery models.

TypeBroad incumbent
Description

Oracle's Clinical One and former Phase Forward/Clintrial CTMS products address the same clinical trial management buyer as SignalPath. As a broad incumbent, Oracle bundles CTMS into a much wider life sciences platform, putting competitive pricing pressure on point solutions.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds5 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

SignalPath

Clinical Trial Management Softwaresignalpath.com

SignalPath is a Raleigh-based clinical research software company building a Clinical Trial Management System (CTMS) for clinical research sites and sponsors, now operating as Verily's Viewpoint Site CTMS within Alphabet's precision health platform.

What SignalPath does

SignalPath is a U.S.-based clinical research software company founded in 2014 and headquartered in Raleigh, North Carolina. The company designs and develops Clinical Trial Management System (CTMS) software intended to improve the operational ease, efficiency, and quality of clinical research at the site and sponsor level. Its core product is a site-focused CTMS that addresses the workflow complexity, data tracking, and quality control demands faced by clinical research organizations conducting trials.

The company's technology stack is built around a proprietary CTMS platform that has been integrated into Verily's broader Viewpoint solution suite — a multi-product offering covering clinical research acceleration, alongside Verily's other products (Pre, Lightpath, Sightline, and Verily Me). The platform positions itself as an enterprise solution for clinical research sites, with a sales-led go-to-market model evidenced by a "Request a demo" engagement flow on the product page. The underlying technology is described within the Viewpoint suite as part of an AI-native precision health platform, indicating architectural alignment with modern, data-driven clinical research workflows.

SignalPath's business model is enterprise B2B SaaS, monetizing through site-level CTMS licenses sold to clinical research organizations and sponsors. The company scaled to 51–100 employees and raised approximately $34.5M across five funding rounds between 2014 and 2019, culminating in a $18M Series 2 in October 2019. The company was subsequently acquired by Verily (an Alphabet subsidiary), where the SignalPath CTMS now operates as Viewpoint Site CTMS within Verily's portfolio. No standalone revenue, customer counts, or pricing details are publicly disclosed.

SignalPath firmographics

Firmographics
Name
SignalPath
Website
https://signalpath.com
Company type
Private
Founded year
2014
Operating status
Operating
Headcount range
1–10 employees
Short description
SignalPath is a Raleigh-based clinical research software company building a Clinical Trial Management System (CTMS) for clinical research sites and sponsors, now operating as Verily's Viewpoint Site CTMS within Alphabet's precision health platform.
Ownership category
akta.pro rank

SignalPath industry classification

Industry
Product category
Clinical Trial Management Software
NAICS
Custom Computer Programming Services (541511), Computer Systems Design Services (541512)
SIC
Services-Prepackaged Software (7372), Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLACAOAD
Clinical Trial Management Systems (CTMS)
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)
SECONDARYHLACAOAL
Decentralized/Hybrid Trial Enablement (DCT) Platforms
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)
SECONDARYHLAGAJAM
Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)

Keywords

  • Clinical trial software
  • Clinical research management
  • Clinical trial management system
  • Research site operations
  • Sponsor clinical software

Where SignalPath is headquartered

Location

Headquarters

HQ city
Raleigh
HQ country
United States
HQ region
North America

Markets served

SignalPath business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations

Distribution channels1 record

Marketing channels1 record

SignalPath product offering

Product offering

Core offering

SignalPath designs and provides the next generation of software for the clinical research site and sponsor. Its flagship offering is a Clinical Trial Management System (CTMS) engineered to improve the ease, efficiency, and quality of clinical research operations for research sites and sponsor organizations.

Product overview

Verily offers a multi-product solution suite called Viewpoint designed to accelerate clinical research. Viewpoint Site CTMS is the core clinical trial management system offering within this suite, focused on improving operational aspects of site-level clinical trials. The Viewpoint suite is part of Verily's broader precision health platform alongside products like Pre (AI-native platform), Lightpath (personalized care), Sightline (population disease monitoring), and Verily Me (personal health companion).

Differentiator

Problem solved

Functional benefit

Products and services

  • Viewpoint Site CTMS A Clinical Trial Management System (CTMS) designed to improve the ease, efficiency, and quality of clinical research operations for clinical research sites and sponsor organizations.

Companies that use SignalPath

Customer profile

Segments1 record

Ideal customer profiles1 record

SignalPath technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

SignalPath partnerships and signals

Strategic signal

Recent moves6 records

Expansion highlights5 records

SignalPath competitors and assessment

Company assessment

Direct peers

  • Veeva Systems: Veeva Systems is the dominant vendor of CTMS, eTMF, EDC and broader clinical operations software to pharma sponsors and CROs. It is the most direct competitor to SignalPath in the CTMS space and is the benchmark incumbent for clinical research SaaS.
  • Castor: Castor provides a clinical trial platform spanning EDC, ePRO and CTMS-style functionality for sites and sponsors. It is an emerging direct peer targeting the same decentralized trial buyer with a modern cloud-native product.
  • Bio-Optronics: Bio-Optronics builds the Clinical Conductor CTMS used by research sites and site management organizations. It is a direct competitor focused on the same research site buyer that SignalPath targets.
  • Advarra: Advarra offers a CTMS (OnCore) alongside IRB and biosafety services targeting academic medical centers and research sites. It directly competes with SignalPath at the site level and is one of the most established site-focused CTMS products in the market.
  • RealTime Software Solutions: RealTime delivers CTMS and eRegulatory solutions for research sites and SMOs. It competes head-on with SignalPath in the investigator-site CTMS category with comparable pricing and SaaS delivery models.

Broad incumbents

  • Medidata (Dassault Systèmes): Medidata offers the Rave CTMS module alongside EDC, eCOA and the Patient Cloud decentralized trial suite. As a broad incumbent owned by Dassault Systèmes, it competes with SignalPath across both sponsor and site clinical operations software.
  • IQVIA Technologies: IQVIA bundles CTMS, EDC, and the broader IQVIA Platform alongside its CRO services. As a broad incumbent CRO-plus-software player, it competes with SignalPath both directly (CTMS) and via integrated services-plus-tech bundles that can foreclose independent site software.
  • Clario: Clario delivers eCOA, ECG, imaging and clinical trial software spanning site and sponsor buyers. It is a broad incumbent with overlapping DCT and clinical operations capabilities that compete with the Viewpoint Site CTMS positioning.
  • Oracle Health Sciences (Clinical One): Oracle's Clinical One and former Phase Forward/Clintrial CTMS products address the same clinical trial management buyer as SignalPath. As a broad incumbent, Oracle bundles CTMS into a much wider life sciences platform, putting competitive pricing pressure on point solutions.

Emerging players

  • Prism Clinical Research: Prism provides CTMS alternatives such as the eResearch suite for academic and community research sites. It is an emerging peer competing for the same site-level buyer with comparable functionality.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

SignalPath social profiles

Digital presence

SignalPath financial estimates

Financial estimate

Revenue estimate

Valuation estimate

SignalPath leadership team

Management profile

Number of profiles

Profiles3 records

SignalPath funding detail

Funding detail

Funding overview

Funding rounds5 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

SignalPath M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SignalPath

What does SignalPath do?

SignalPath designs and provides the next generation of software for the clinical research site and sponsor. Its flagship offering is a Clinical Trial Management System (CTMS) engineered to improve the ease, efficiency, and quality of clinical research operations for research sites and sponsor organizations.

Is SignalPath a public or private company?

SignalPath is a private company. It is classified as venture growth investor backed and is currently operating.

When was SignalPath founded?

SignalPath was founded in 2014. It employs 1 to 10 people.

Where is SignalPath based?

SignalPath is headquartered in Raleigh, United States, in the North America region.

Who are SignalPath's main competitors?

Direct peers on record are Veeva Systems, Castor, Bio-Optronics, Advarra and RealTime Software Solutions. Broad incumbents are Medidata (Dassault Systèmes), IQVIA Technologies, Clario and Oracle Health Sciences (Clinical One). Prism Clinical Research is listed as an emerging player.

Does SignalPath have an API?

No public API is recorded for SignalPath.

What industry is SignalPath in?

SignalPath's product category is Clinical Trial Management Software. Its primary akta.pro industry code is HLACAOAD, Clinical Trial Management Systems (CTMS), with a secondary code of HLACAOAL, Decentralized/Hybrid Trial Enablement (DCT) Platforms. Its NAICS code is 541511 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PendoWhat is User Onboarding? Definition and examplesThis article defines user onboarding as the process of helping new users become proficient in an application, emphasizing its role in reducing churn and accelerating time to value. It outlines key metrics for measuring effectiveness, such as completion rates and retention, while highlighting best practices like personalized in-app guidance and tailored experiences for different user segments. The piece also provides examples from companies like Verizon Connect, ShippingEasy, MagHub, and SignalPath to illustrate successful implementation strategies.TradingViewSignalPush, a Binary Options Signal Provider, Fined $100,000The US CFTC received a court order fining BareIt Media LLC, operating as SignalPush, $100,000 and imposing a permanent injunction. The order bars the defendants from acting as commodity trading advisors without CFTC registration, as they operated unregistered from May 2013 to 2017.NewswireHoduSoft Partners With CPaaS Provider Signalmash to Serve US MarketHoduSoft announced a partnership with US CPaaS provider Signalmash to integrate their unified communications software. HoduSoft offers contact center, IP PBX, and broadcasting software, while Signalmash provides voice and text messaging APIs. The collaboration aims to deliver a turnkey omni-channel solution to customers.BioSpaceVerily Completes Acquisition of SignalPath, Expanding Company’s Clinical Research Capabilities and Marking Company’s First Major AcquisitionVerily completed its acquisition of SignalPath, expanding its clinical research capabilities. The deal strengthens Verily's Baseline platform and adds SignalPath's CTMS, with about 100 employees joining Verily's clinical research business. SignalPath will remain in Raleigh, increasing Verily's footprint in North Carolina.BioSpaceVerily Folds in SignalPath to Enhance Trial Efficiency and ExecutionVerily acquired SignalPath, a clinical trial management system, to support its Baseline platform. Financial terms were not disclosed. The acquisition aims to improve trial efficiency and expand Verily's clinical research capabilities.trib.alVerily adds to its clinical trials toolbox with acquisition of startup SignalPathVerily announced an acquisition of SignalPath, a clinical trial management startup, with financial terms undisclosed. SignalPath, co-founded in 2014, has raised nearly $34 million, including an $18 million Series B in 2019. The deal aims to expand Verily's platform for hybrid and decentralized clinical trials.HIT ConsultantVerily Acquires Clinical Trials Management Platform SignalPath, Marks First AcquisitionVerily announced an agreement to acquire SignalPath, a Raleigh-based clinical trial management platform, marking its first major acquisition. Financial terms were not disclosed. The deal will integrate SignalPath into Verily's Baseline platform and expand its clinical research footprint in North Carolina.VerilyVerily to Acquire SignalPath, Expanding Company's Clinical Research CapabilitiesVerily, an Alphabet company, and SignalPath announced on August 17, 2021 that they have entered an agreement for Verily to acquire SignalPath, a privately held Raleigh-based developer of a clinical trial management system. SignalPath employees will join Verily's clinical research business at closing, retaining their Raleigh presence. The deal amount was not disclosed.BioSpaceVerily to Acquire SignalPath, Expanding Company’s Clinical Research CapabilitiesVerily, an Alphabet subsidiary, has entered into an agreement to acquire SignalPath, a developer of clinical trial management systems based in Raleigh. This transaction aims to expand Verily's Baseline platform capabilities, enhancing the efficiency and speed of clinical research by integrating SignalPath's technology with Verily's existing resources. The acquisition allows SignalPath to scale its solutions while increasing Verily's geographic footprint in North Carolina.FinSMEsSignalPath Closes $18M Series B FundingSignalPath, a Raleigh-based clinical trial technology startup, closed an $18M Series B funding round, bringing total funding to $35M. The company will use the funds to grow its research teams and products. Its platform currently supports over 2,500 trials across 250 sites and 3,000 active users.